Recently, an EU-based large pharma company outlined that as part of their Corporate Social Responsibility strategy they created a not-for-profit Global Healthcare organization enabling the world's poorest 40 countries to access and continuously supply 30 essential medicines. The organization donates 100,000 ampoules (small-sealed vials) annually to treat patients with rare disease1.
This is a clear example of the sectors paradigm shift towards ESG values to positively influence the ethical development of their business.
1. Environment, Health, Safety and Sustainability (efpia.eu), 2022